Company news
Actavia Life Sciences, Inc. (OTC:RASP) news
Actavia Life Sciences, Inc. news releases on 6ix. Latest, Jan 3, 2018: Rasna Therapeutics, Inc., Announces Follow Up Phase II Clinical Data Confirming…
Press releases & updates
Rasna Therapeutics, Inc., Announces Follow Up Phase II Clinical Data Confirming Efficacy of Actinomycin D in Patients with NPM1-Mutated Acute Myeloid Leukemia
January 3, 2018
Rasna Therapeutics Names Dr. Kunwar Shailubhai As New CEO
April 20, 2017
Rasna Therapeutics Announces Upgrade to OTCQX®
April 12, 2017
OTC Markets Group Welcomes Rasna Therapeutics to OTCQX
April 12, 2017
Rasna Therapeutics, Inc. Closes Private Placement of $2 Million
December 27, 2016
Rasna Therapeutics, Inc. Appoints Dr Alessandro Padova as Chairman
October 18, 2016
Rasna Therapeutics, Inc. Announces Forward Split of Common Stock, Name Change & Ticker Change to RASP
September 27, 2016
OTC Markets Group Welcomes Newly Verified OTCQB Companies – September 8
September 8, 2016